Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Generics giant and Novartis division Sandoz signed a deal with Astellas for worldwide rights to the antifungal drug micafungin sodium, also known as Mycamine. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.